Watson M. (1997) Management of patients with osteoarthritis. Pharm. J 259:296-297.
Levy E., Ferme A., Perocheau D., Bono I. (1993) Les couts socio-economiques de l'arthrose en France. Rev. Rhum. Ed. Fr 60.
(2001) Prevalence of Arthritis-United States, 1997. MMWR. Morb. Mortal. Wkly. Rep , Centers for Disease Control; 50:334-336.
Sprangers M.A.G., de Regt E.B., Andries F. (2000) Which chronic conditions are associated with a better or poorer quality of life?. J. Clin. Epidemiol 53:895-907.
Becker N., Bondegaard T.A., Olsen A.K., Sjogren O., Bech P., Eriksen J. (1997) Pain epidemiology and health related quality of life in chronic non-malignant pain patients referred to a Danish multi-disciplinary pain center. Pain 73:393-400.
Gureje O., Von Korff M., Simon G.E., Gater R. (1998) Persistent pain and well-being: A WHO study in primary care. J. Am. Med. Assoc 280:147-151.
(1993) World development report 1993: Investing in health., World Bank. New York: Oxford University Press for the World Bank; .
Murray C.J.L., Lopez A.D. (1996) Global burden of disease and injury series, Vol. I. The global burden of disease: A comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020., eds. Cambridge, MA: Harvard School of Public Health on behalf of the World Health Organization and the World Bank; .
Cockel R. (1987) NSAIDs-should every prescription carry a government health warning?. Gut 28:515-518.
Fries J.F. (1991) NSAID gastropathy: The second most deadly rheumatic disease? Epidemiology and risk appraisal. J. Rheumatol. Suppl 28:6-10.
Armstrong C.P., Blower A.L. (1987) Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut 28:527-532.
FitzGerald G.A., Patrono C. (2001) The coxibs, selective inhibitors of cyclooxygenase-2. N. Engl. J. Med 345:433-442.
